Sector ratings Avacta Group Plc

Equities

Market Closed - London S.E. Other stock markets 11:35:03 2026-05-15 am EDT			5-day change	1st Jan Change
86.50 ^GBX	-0.46%		+4.85%	+49.14%

May. 06	Avacta Therapeutics Presents New Comparisons Of Pre\|CISION Payload Release Versus Approved ADCs And AVA6207 Dual Payload Delivery	CI
Apr. 21	Vaalco says remainder of 2026 to be "very profitable"	AN

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
AVACTA GROUP PLC	522M	-	B	-		-
ARGENX SE	50.1B		A
WUXI APPTEC CO., LTD.	45.82B		AAA
INSMED INCORPORATED	23.66B	-	A	-		-
BIONTECH SE	22.65B	-	-	-		-
WUXI BIOLOGICS (CAYMAN) INC.	17.8B		AAA
GENMAB A/S	16.08B		A
AKESO, INC.	14.14B		B
SUMMIT THERAPEUTICS INC.	13.09B	-	-	-		-
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	13B	-	AA	-		-
EXELIXIS, INC.	12.6B		BB
MADRIGAL PHARMACEUTICALS, INC.	12.07B	-	B	-		-
ARROWHEAD PHARMACEUTICALS, INC.	10.8B	-	BB	-		-
PHARMAESSENTIA CORPORATION	9.73B		AA
CYTOKINETICS, INCORPORATED	10.3B	-	AA	-		-
SAMSUNG EPIS HOLDINGS CO., LTD.	8.42B		AA				-
IMMUNITYBIO, INC.	8.35B	-	CCC	-		-
REMEGEN CO., LTD.	8.32B		-
CEREVEL THERAPEUTICS HOLDINGS, INC.	8.19B	-	-	-	-	-	-	-
NUVALENT, INC.	8.08B	-	CCC	-		-
Average	15.69B		A
Weighted average by Cap.			A